183 related articles for article (PubMed ID: 24673112)
1. Impaired resolution of inflammation in human chronic heart failure.
Reina-Couto M; Carvalho J; Valente MJ; Vale L; Afonso J; Carvalho F; Bettencourt P; Sousa T; Albino-Teixeira A
Eur J Clin Invest; 2014 Jun; 44(6):527-38. PubMed ID: 24673112
[TBL] [Abstract][Full Text] [Related]
2. Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients.
Goicoechea M; Sanchez-Niño MD; Ortiz A; García de Vinuesa S; Quiroga B; Bernis C; Morales E; Fernández-Juarez G; de Sequera P; Verdalles U; Verde E; Luño J
Prostaglandins Leukot Essent Fatty Acids; 2017 Oct; 125():8-13. PubMed ID: 28987723
[TBL] [Abstract][Full Text] [Related]
3. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Huang MH; Perez-Polo JR; Uretsky BF
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):89-98. PubMed ID: 17259075
[TBL] [Abstract][Full Text] [Related]
4. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
[TBL] [Abstract][Full Text] [Related]
5. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
Chiang N; Takano T; Clish CB; Petasis NA; Tai HH; Serhan CN
J Pharmacol Exp Ther; 1998 Nov; 287(2):779-90. PubMed ID: 9808710
[TBL] [Abstract][Full Text] [Related]
6. Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4.
Planagumà A; Titos E; López-Parra M; Gaya J; Pueyo G; Arroyo V; Clària J
FASEB J; 2002 Dec; 16(14):1937-9. PubMed ID: 12368230
[TBL] [Abstract][Full Text] [Related]
7. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
Menezes-de-Lima O; Kassuya CA; Nascimento AF; Henriques Md; Calixto JB
Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):123-35. PubMed ID: 16939877
[TBL] [Abstract][Full Text] [Related]
8. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.
Clària J; Lee MH; Serhan CN
Mol Med; 1996 Sep; 2(5):583-96. PubMed ID: 8898374
[TBL] [Abstract][Full Text] [Related]
9. Low-dose aspirin increases 15-epi-lipoxins A
Gonzalez-Brown VM; Ma'ayeh M; Kniss DA; Cackovic M; Landon MB; Rood KM
Pregnancy Hypertens; 2021 Dec; 26():75-78. PubMed ID: 34563982
[TBL] [Abstract][Full Text] [Related]
10. The effect of aspirin on gingival crevicular fluid levels of inflammatory and anti-inflammatory mediators in patients with gingivitis.
Kim DM; Koszeghy KL; Badovinac RL; Kawai T; Hosokawa I; Howell TH; Karimbux NY
J Periodontol; 2007 Aug; 78(8):1620-6. PubMed ID: 17668982
[TBL] [Abstract][Full Text] [Related]
11. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
Takano T; Fiore S; Maddox JF; Brady HR; Petasis NA; Serhan CN
J Exp Med; 1997 May; 185(9):1693-704. PubMed ID: 9151906
[TBL] [Abstract][Full Text] [Related]
12. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
[TBL] [Abstract][Full Text] [Related]
13. LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation.
Gewirtz AT; Fokin VV; Petasis NA; Serhan CN; Madara JL
Am J Physiol; 1999 Apr; 276(4):C988-94. PubMed ID: 10199831
[TBL] [Abstract][Full Text] [Related]
14. Different characteristics of chronic heart failure (CHF) in elderly diabetics and non-diabetics.
Romeo R; Scalisi C; Tafuri L; Romeo A; Maugeri D; Sorace R
Arch Gerontol Geriatr; 2010; 50(1):101-4. PubMed ID: 19371958
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure.
Jankowska EA; Ponikowska B; Majda J; Zymlinski R; Trzaska M; Reczuch K; Borodulin-Nadzieja L; Banasiak W; Ponikowski P
Int J Cardiol; 2007 Feb; 115(2):151-5. PubMed ID: 16782216
[TBL] [Abstract][Full Text] [Related]
16. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
[TBL] [Abstract][Full Text] [Related]
17. [Change of serum myeloperoxidase and lipoxin A4 level in coronary heart disease patients with anxiety and/or depression].
Liang S; Li X; Huang W; Gong H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):370-5. PubMed ID: 23645243
[TBL] [Abstract][Full Text] [Related]
18. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
Serhan CN; Chiang N
ScientificWorldJournal; 2002 Jan; 2():169-204. PubMed ID: 12806051
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of hyponatremia with plasma renin activity, antidiuretic hormone and brain natriuretic peptide in chronic heart failure].
Fu L; Ge HL; Li J; Chen GY; Li YS; Xie RS; Fan CY
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):781-3. PubMed ID: 17217682
[TBL] [Abstract][Full Text] [Related]
20. Decrease of serum levels of the anti-inflammatory cytokine interleukin-10 in patients with advanced chronic heart failure.
Stumpf C; Lehner C; Yilmaz A; Daniel WG; Garlichs CD
Clin Sci (Lond); 2003 Jul; 105(1):45-50. PubMed ID: 12639217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
